Date Range
Date Range
Date Range
Advanced therapies inspired for you. Defymed is a company that develops and markets implantable bio-artificial medical devices for diverse therapeutic applications. Our basic aim is to develop breakthrough innovations that enhance drug delivery systems leading to improvements in the quality of life of patients. Séverine Sigrist, Defymed CEO. Million diabetics worldwide forecasted for 2045. Billion per year spent on diabetes-related expenses. Strasbourg, France, February .
MT1000 - Essai de cristallisation. AXONE, SYNAPSE, FOVEA, IRIS, e-Remora.
TeBactEn is a tool designed to facilitate the retrieval, extraction and annotation of bacterial enzymatic reactions and pathways from the literature. The system has been developed in the context of the Microme. In case of all three TeBactEn data collections, an exhaustive recognition of mentions of all species and taxonomic entities was carried out. Identification of metabolism relevant articles.
Viernes, 14 de febrero de 2014. Y mantente al día con nuestras novedades y ofertas. En nuestro fanpage podrás también revisar nuestro catálogo, y hacer pedidos y consultas. Viernes, 18 de octubre de 2013.